Stress triggers coronary mast cells leading to cardiac events

Annals of Allergy, Asthma and Immunology

Volumn 112, Issue 4, 2014, Pages 309-316

  Alevizos, Michail ^a,b   Karagkouni, Anna ^a,c   Panagiotidou, Smaro ^a   Vasiadi, Magdalini ^a   Theoharides, Theoharis C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Jacobi Medical   (United States)

^c Department of Psychiatry Westchester Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ANTIHISTAMINIC AGENT; CORTICOTROPIN RELEASING FACTOR; CROMOGLYCATE DISODIUM; FLAVONE; FLAVONOL; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPROTEIN; LUTEOLIN; NEUROTENSIN; NICOTINIC ACID; QUERCETIN; RUPATADINE; THROMBOCYTE ACTIVATING FACTOR; UROCORTIN;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL ACTIVATION; CELL STIMULATION; CORONARY ARTERY DISEASE; CORONARY HYPERSENSITIVITY SYNDROME; CORONARY INFLAMMATION; CORONARY MAST CELL; CYTOKINE RELEASE; DIETARY INTAKE; DISEASE ASSOCIATION; DRUG EFFECT; ERYTHEMA; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HORMONE RELEASE; HUMAN; HYPERSENSITIVITY; INFLAMMATION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PRURITUS; RECEPTOR UPREGULATION; REVIEW; STRESS;

ANIMALS; CELL DEGRANULATION; CORONARY ARTERY DISEASE; CORONARY VESSELS; CORTICOTROPIN-RELEASING HORMONE; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; MAST CELLS; STRESS, PSYCHOLOGICAL;

EID: 84897130397     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2013.09.017     Document Type: Review

References (188)

1. T.C. Theoharides, and D.E. Cochrane Critical role of mast cells in inflammatory diseases and the effect of acute stress J Neuroimmunol 146 2004 1 12
2. R.J. Wright, R.T. Cohen, and S. Cohen The impact of stress on the development and expression of atopy Curr Opin Allergy Clin Immunol 5 2005 23 29
3. M.J. Slattery Psychiatric comorbidity associated with atopic disorders in children and adolescents Immunol Allergy Clin North Am 25 2005 407 420 viii
4. Y. Chida, M. Hamer, and A. Steptoe A bidirectional relationship between psychosocial factors and atopic disorders: a systematic review and meta-analysis Psychosom Med 70 2008 102 116
5. E. Chen, and G.E. Miller Stress and inflammation in exacerbations of asthma Brain Behav Immun 21 2007 993 999
6. T.C. Theoharides, S. Enakuua, N. Sismanopoulos, E. Papadimas, A. Angelidou, and K. Alysandratos Stress contributes to asthma worsening through mast cell activation Ann Allergy Asthma Immunol 109 2012 14 19
7. K. Seiffert, E. Hilbert, H. Schaechinger, C.C. Zouboulis, and H.C. Deter Psychophysiological reactivity under mental stress in atopic dermatitis Dermatology 210 2005 286 293
8. J.L. Peters, S. Cohen, J. Staudenmayer, J. Hosen, T.A. Platts-Mills, and R.J. Wright Prenatal negative life events increases cord blood IgE: interactions with dust mite allergen and maternal atopy Allergy 67 2012 545 551
9. W. Jiang, M. Babyak, and D.S. Krantz et al. Mental stress-induced myocardial ischemia and cardiac events JAMA 275 1996 1651 1656
10. J.E. Deanfield, M. Shea, and M. Kensett et al. Silent myocardial ischaemia due to mental stress Lancet 2 1984 1001 1005
11. A. Rozanski, C.N. Bairey, and D.S. Krantz et al. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease N Engl J Med 318 1988 1005 1012
12. P.C. Deedwania Mental stress, pain perception and risk of silent ischemia J Am Coll Cardiol 25 1995 1504 1506
13. A. Steptoe, and M. Kivimaki Stress and cardiovascular disease Nat Rev Cardiol 9 2012 360 370
14. H. Nabi, M. Kivimaki, and G.D. Batty et al. Increased risk of coronary heart disease among individuals reporting adverse impact of stress on their health: the Whitehall II prospective cohort study Eur Heart J 34 2013 2697 2705
15. J.E. Ferrie, M. Kivimaki, M.J. Shipley, S.G. Davey, and M. Virtanen Job insecurity and incident coronary heart disease: the Whitehall II prospective cohort study Atherosclerosis 227 2013 178 181
16. W. Jiang, Z. Samad, and S. Boyle et al. Prevalence and clinical characteristics of mental stress-induced myocardial ischemia in patients with coronary heart disease J Am Coll Cardiol 61 2013 714 722
17. S.V. Arnold, K.G. Smolderen, D.M. Buchanan, Y. Li, and J.A. Spertus Perceived stress in myocardial infarction: long-term mortality and health status outcomes J Am Coll Cardiol 60 2012 1756 1763
18. S. Richardson, J.A. Shaffer, L. Falzon, D. Krupka, K.W. Davidson, and D. Edmondson Meta-analysis of perceived stress and its association with incident coronary heart disease Am J Cardiol 110 2012 1711 1716
19. M. Kivimaki, S.T. Nyberg, and G.D. Batty et al. Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data Lancet 380 2012 1491 1497
20. S. Toker, S. Melamed, S. Berliner, D. Zeltser, and I. Shapira Burnout and risk of coronary heart disease: a prospective study of 8838 employees Psychosom Med 74 2012 840 847
21. N. Slopen, R.J. Glynn, J.E. Buring, T.T. Lewis, D.R. Williams, and M.A. Albert Job strain, job insecurity, and incident cardiovascular disease in the Women's Health Study: results from a 10-year prospective study PloS One 7 2012 e40512
22. R. Emeny, M.E. Lacruz, and J. Baumert et al. Job strain associated CRP is mediated by leisure time physical activity: results from the MONICA/KORA study Brain Behav Immun 26 2012 1077 1084
23. E.S. Soteriades, D.L. Smith, A.J. Tsismenakis, D.M. Baur, and S.N. Kales Cardiovascular disease in US firefighters: a systematic review Cardiol Rev 19 2011 202 215
24. T.C. Theoharides, N. Sismanopoulos, D.A. Delivanis, B. Zhang, E.E. Hatziagelaki, and D. Kalogeromitros Mast cells squeeze the heart and stretch the gird: their role in atherosclerosis and obesity Trends Pharmacol Sci 32 2011 534 542
25. N. Sismanopoulos, D.A. Delivanis, D. Mavrommati, E. Hatziagelaki, P. Conti, and T.C. Theoharides Do mast cells link obesity and asthma? Allergy 68 2013 8 15
26. M. Chrostowska, A. Szyndler, M. Hoffmann, and K. Narkiewicz Impact of obesity on cardiovascular health Best Pract Res Clin Endocrinol Metab 27 2013 147 156
27. P. Matusik, B. Guzik, C. Weber, and T.J. Guzik Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice? Thromb Haemost 108 2012 443 456
28. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
29. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
30. A.T. Slominski, M.A. Zmijewski, B. Zbytek, D.J. Tobin, T.C. Theoharides, and J. Rivier Key role of CRF in the skin stress response system Endocr Rev 34 2013 827 884
31. J. Cao, N. Papadopoulou, and D. Kempuraj et al. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor J Immunol 174 2005 7665 7675
32. H. Markel "Who's on first?" - medical discoveries and scientific priority N Engl J Med 351 2004 2792 2794
33. T.C. Theoharides, J.M. Donelan, N. Papadopoulou, J. Cao, D. Kempuraj, and P. Conti Mast cells as targets of corticotropin-releasing factor and related peptides Trends Pharmacol Sci 25 2004 563 568
34. D. Kempuraj, N.G. Papadopoulou, and M. Lytinas et al. Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells Endocrinology 145 2004 43 48
35. S.H. Oh, C.O. Park, and W.H. Wu et al. Corticotropin-releasing hormone downregulates IL-10 production by adaptive forkhead box protein 3-negative regulatory T cells in patients with atopic dermatitis J Allergy Clin Immunol 129 2012 151 159
36. M. O'Kane, E.P. Murphy, and B. Kirby The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease Exp Dermatol 15 2006 143 153
37. A. Slominski On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders Br J Dermatol 160 2009 229 232
38. W.C. Mustain, P.G. Rychahou, and B.M. Evers The role of neurotensin in physiologic and pathologic processes Curr Opin Endocrinol Diabetes Obes 18 2011 75 82
39. J. Donelan, W. Boucher, N. Papadopoulou, M. Lytinas, D. Papaliodis, and T.C. Theoharides Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process Proc Natl Acad Sci U S A 103 2006 7759 7764
40. R.S. Feldberg, D.E. Cochrane, and R.E. Carraway et al. Evidence for a neurotensin receptor in rat serosal mast cells Inflamm Res 47 1998 245 250
41. T.C. Theoharides, L.K. Singh, and W. Boucher et al. Corticotropin- releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects Endocrinology 139 1998 403 413
42. R. Crompton, V.L. Clifton, A.T. Bisits, M.A. Read, R. Smith, and I.M. Wright Corticotropin-releasing hormone causes vasodilation in human skin via mast cell-dependent pathways J Clin Endocrinol Metab 88 2003 5427 5432
43. M. Vasiadi, A. Therianou, and K.D. Alysandratos et al. Serum neurotensin (NT) is increased in psoriasis and NT induces VEGF release from human mast cells Br J Dermatol 166 2012 1349 1352
44. M. Vasiadi, A. Mondolfi, and K.-D. Alysandratos et al. Neurotensin serum levels and skin gene expression are increased in atopic dermatitis Br J Dermatol 166 2013 1349 1352
45. G.P. Chrousos The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation N Engl J Med 332 1995 1351 1362
46. D.S. Krantz, D.S. Sheps, R.M. Carney, and B.H. Natelson Effects of mental stress in patients with coronary artery disease: evidence and clinical implications JAMA 283 2000 1800 1802
47. K. Kageyama, and T. Suda Urocortin-related peptides increase interleukin-6 output via cyclic adenosine 5′-monophosphate-dependent pathways in A7r5 aortic smooth muscle cells Endocrinology 144 2003 2234 2241
48. M. Huang, D. Kempuraj, and N. Papadopoulou et al. Urocortin induces interleukin-6 release from rat cardiomyocytes through p38 MAP kinase, ERK and NF-kappaB activation J Mol Endocrinol 42 2009 397 405
49. D.S. Latchman Urocortin protects against ischemic injury via a MAPK-dependent pathway Trends Cardiovasc Med 11 2003 169
50. D. Schulman, D.S. Latchman, and D.M. Yellon Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway Am J Physiol Heart Circ Physiol 283 2003 H1481 H1488
51. B.K. Brar, A.K. Jonassen, and E.M. Egorina et al. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart Endocrinology 145 2004 24 35
52. E.A. Woodcock Ucn-II and Ucn-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for CRFR2 in the murine heart Endocrinology 145 2004 21 23
53. A.M. Chen, M.H. Perrin, and M.R. Digruccio et al. A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity Proc Natl Acad Sci U S A 102 2005 2620 2625
54. C. Tsatsanis, A. Androulidaki, E. Dermitzaki, A. Gravanis, and A.N. Margioris Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2 J Cell Physiol 210 2007 774 783
55. M.A. Beaven Our perception of the mast cell from Paul Ehrlich to now Eur J Immunol 39 2009 11 25
56. Y.A. Mekori, and D.D. Metcalfe Mast cells in innate immunity Immunol Rev 173 2000 131 140
57. S.J. Galli, M. Tsai, and A.M. Piliponsky The development of allergic inflammation Nature 454 2008 445 454
58. J. Gong, N.S. Yang, and M. Croft et al. The antigen presentation function of bone marrow-derived mast cells is spatiotemporally restricted to a subset expressing high levels of cell surface FcepsilonRI and MHC II BMC Immunol 11 2010 34
59. T.C. Theoharides, K.D. Alysandratos, and A. Angelidou et al. Mast cells and inflammation Biochim Biophys Acta 1822 2010 21 33
60. M.F. Gurish, and J.A. Boyce Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell J Allergy Clin Immunol 117 2006 1285 1291
61. A.M. Dvorak Mast-cell degranulation in human hearts N Engl J Med 315 1986 969 970
62. V. Patella, G. de Crescenzo, A. Ciccarelli, I. Marino, M. Adt, and G. Marone Human heart mast cells: a definitive case of mast cell heterogeneity Int Arch Allergy Immunol 106 1995 386 393
63. P. Constantinides Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction Circulation 92 1995 1083 1088
64. P. Laine, M. Kaartinen, A. Penttilä, P. Panula, T. Paavonen, and P.T. Kovanen Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery Circulation 99 1999 361 369
65. J. Kelley, G. Hemontolor, W. Younis, C. Li, G. Krishnaswamy, and D.S. Chi Mast cell activation by lipoproteins Methods Mol Biol 315 2006 341 348
66. N.G. Frangogiannis, C.W. Smith, and M.L. Entman The inflammatory response in myocardial infarction Cardiovasc Res 53 2002 31 47
67. I. Bot, S.C. de Jager, and M. Bot et al. The neuropeptide substance P mediates adventitial mast cell activation and induces intraplaque hemorrhage in advanced atherosclerosis Circ Res 106 2010 89 92
68. R. Quirion, F. Rioux, D. Regoli, and S. St-Pierre Selective blockade of neurotensin-induced coronary vessel constriction in perfused rat hearts by a neurotensin analogue Eur J Pharmacol 61 1980 309 312
69. X. Pang, N. Alexacos, and R. Letourneau et al. A neurotensin receptor antagonist inhibits acute immobilization stress-induced cardiac mast cell degranulation, a corticotropin-releasing hormone-dependent process J Pharmacol Exp Ther 287 1998 307 314
70. E.J. Swindle, and D.D. Metcalfe The role of reactive oxygen species and nitric oxide in mast cell-dependent inflammatory processes Immunol Rev 217 2007 186 205
71. M. Tagen, A. Elorza, W. Boucher, C.L. Kepley, O. Shirihai, and T.C. Theoharides Mitochondrial uncoupling protein 2 (UCP2) inhibits mast cell activation and reduces histamine content J Immunol 183 2009 6313 6319
72. T.C. Theoharides, B. Zhang, and D. Kempuraj et al. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin Proc Natl Acad Sci U S A 107 2010 4448 4453
73. B. Zhang, K.D. Alysandratos, and A. Angelidou et al. Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: relevance to atopic dermatitis J Allergy Clin Immunol 127 2011 1522 1531
74. B. Zhang, S. Asadi, Z. Weng, N. Sismanopoulos, and T.C. Theoharides Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions PloS One 7 2012 e49767
75. J. Sun, G.K. Sukhova, and P.J. Wolters et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines Nat Med 13 2007 719 724
76. H.M. Heikkila, J. Trosien, and J. Metso et al. Mast cells promote atherosclerosis by inducing both an atherogenic lipid profile and vascular inflammation J Cell Biochem 109 2010 615 623
77. E.N. Deliargyris, R.J. Raymond, T.C. Theoharides, W.S. Boucher, D.A. Tate, and G.J. Dehmer Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure Am J Cardiol 86 2000 913 918
78. Y. Miyao, H. Yasue, and H. Ogawa et al. Elevated plasma interleukin-6 levels in patients with acute myocardial infarction Am Heart J 126 1993 1299 1304
79. M. Suzuki, S. Inaba, T. Nagai, H. Tatsuno, and Y. Kazatani Relation of C-reactive protein and interleukin-6 to culprit coronary artery plaque size in patients with acute myocardial infarction Am J Cardiol 91 2003 331 333
80. J.K. Pai, T. Pischon, and J. Ma et al. Inflammatory markers and the risk of coronary heart disease in men and women N Engl J Med 351 2004 2599 2610
81. E.Z. Fisman, M. Benderly, and R.J. Esper et al. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction Am J Cardiol 98 2006 14 18
82. M. Huang, X. Pang, K. Karalis, and T.C. Theoharides Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in apolipoprotein E knockout mice Cardiovasc Res 59 2003 241 249
83. K. Bhattacharya, K. Farwell, and M. Huang et al. Mast cell deficient W/Wv mice have lower serum IL-6 and less cardiac tissue necrosis than their normal littermates following myocardial ischemia-reperfusion Int J Immunopathol Pharmacol 20 2007 69 74
84. K. Kandere-Grzybowska, D. Kempuraj, J. Cao, C.L. Cetrulo, and T.C. Theoharides Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin Br J Pharmacol 148 2006 208 215
85. T.C. Theoharides, D. Kempuraj, M. Tagen, P. Conti, and D. Kalogeromitros Differential release of mast cell mediators and the pathogenesis of inflammation Immunol Rev 217 2007 65 78
86. Y. Nakamura, L. Franchi, N. Kambe, G. Meng, W. Strober, and G. Nunez Critical role for mast cells in interleukin-1beta-driven skin inflammation associated with an activating mutation in the nlrp3 protein Immunity 37 2012 85 95
87. Y. Nakamura, N. Kambe, and M. Saito et al. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria J Exp Med 206 2009 1037 1046
88. M. Kaartinen, A. Penttilä, and P.T. Kovanen Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-α Circulation 94 1996 2787 2792
89. J.R. Gordon, and S.J. Galli Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses J Exp Med 174 1991 103 107
90. C.J. Mackins, S. Kano, and N. Seyedi et al. Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia-reperfusion J Clin Invest 116 2006 1063 1070
91. S. Nakae, H. Suto, and M. Iikura et al. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF J Immunol 176 2006 2238 2248
92. D. Baram, G.G. Vaday, P. Salamon, I. Drucker, R. Hershkoviz, and Y.A. Mekori Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha J Immunol 167 2001 4008 4016
93. M.I. Mayranpaa, H.M. Heikkila, K.A. Lindstedt, A.F. Walls, and P.T. Kovanen Desquamation of human coronary artery endothelium by human mast cell proteases: implications for plaque erosion Coron Artery Dis 17 2006 611 621
94. C.N. Jin, H. Ma, Y. Lin, J.A. Wang, and M.X. Xiang Association between SNP rs1800875, serum chymase and immunoglobulin E levels in patients with coronary heart disease J Zhejiang Univ Sci B 12 2011 660 667
95. M. Molino, E.S. Barnathan, and R. Numerof et al. Interactions of mast cell tryptase with thrombin receptors and PAR-2 J Biol Chem 272 1997 4043 4049
96. E.N. Deliargyris, B. Upadhya, and D.C. Sane et al. Mast cell tryptase: a new biomarker in patients with stable coronary artery disease Atherosclerosis 178 2005 381 386
97. N.G. Kounis, G. Tsigkas, G. Almpanis, G.N. Kounis, A. Mazarakis, and G. Hahalis Tryptase levels in coronary syndromes and in hypersensitivity episodes: a common pathway towards Kounis syndrome Atherosclerosis 219 2011 28 29
98. Y. Sakata, K. Komamura, and A. Hirayama et al. Elevation of the plasma histamine concentration in the coronary circulation in patients with variant angina Am J Cardiol 77 1996 1121 1126
99. S. Clejan, S. Japa, C. Clemetson, S.S. Hasabnis, O. David, and J.V. Talano Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis J Cell Mol Med 6 2002 583 592
100. V. Zdravkovic, S. Pantovic, and G. Rosic et al. Histamine blood concentration in ischemic heart disease patients J Biomed Biotechnol 2011 2011 315709
101. Y. Li, L. Chi, D.J. Stechschulte, and K.N. Dileepan Histamine-induced production of interleukin-6 and interleukin-8 by human coronary artery endothelial cells is enhanced by endotoxin and tumor necrosis factor-alpha Microvas Res 61 2001 253 262
102. G. Riccioni, A. Zanasi, N. Vitulano, B. Mancini, and N. D'Orazio Leukotrienes in atherosclerosis: new target insights and future therapy perspectives Mediators Inflamm 2009 2009 737282
103. R. Spanbroek, R. Grabner, and K. Lotzer et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis Proc Natl Acad Sci U S A 100 2003 1238 1243
104. C.A. Demopoulos, R.N. Pinckard, and D.J. Hanahan Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators) J Biol Chem 254 1979 9355 9358
105. A. Kasperska-Zajac, Z. Brzoza, and B. Rogala Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy Recent Pat Inflamm Allergy Drug Discov 2 2008 72 76
106. A. Kasperska-Zajac, Z. Brzoza, and B. Rogala Platelet activating factor as a mediator and therapeutic approach in bronchial asthma Inflammation 31 2008 112 120
107. P. Vadas, M. Gold, and B. Perelman et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis N Engl J Med 358 2008 28 35
108. M.M. Rumore, and K.S. Kim Potential role of salicylates in type 2 diabetes Ann Pharmacother 44 2010 1207 1221
109. F. Enseleit, I. Sudano, and D. Periat et al. Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study Eur Heart J 33 2012 1589 1597
110. M.J. Caslake, and C.J. Packard Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease Curr Opin Lipidol 14 2003 347 352
111. B.S. Sutton, D.R. Crosslin, and S.H. Shah et al. Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets Hum Mol Genet 17 2008 1318 1328
112. M. Xue, K.J. Chen, and H.J. Yin Relationship between platelet activation related factors and polymorphism of related genes in patients with coronary heart disease of blood-stasis syndrome Chin J Integr Med 14 2008 267 273
113. S. Blankenberg, D. Stengel, and H.J. Rupprecht et al. Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis J Lipid Res 44 2003 1381 1386
114. K. Winkler, B.R. Winkelmann, and H. Scharnagl et al. Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health Study Circulation 111 2005 980 987
115. E. Ninio Letter regarding article by Winkler et al, "Platelet- activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health Study." Circulation 112 2005 e108 e109
116. S. Samsamshariat, G. Basati, A. Movahedian, M. Pourfarzam, and N. Sarrafzadegan Elevated plasma platelet-activating factor acetylhydrolase activity and its relationship to the presence of coronary artery disease J Res Med Sci 16 2011 674 679
117. G.H. Zheng, S.Q. Xiong, L.J. Mei, H.Y. Chen, T. Wang, and J.F. Chu Elevated plasma platelet activating factor, platelet activating factor acetylhydrolase levels and risk of coronary heart disease or blood stasis syndrome of coronary heart disease in Chinese: a case control study: a case-control study Inflammation 35 2012 1419 1428
118. G. Mazereeuw, N. Herrmann, and S.A. Bennett et al. Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration Neurosci Biobehav Rev 37 2013 1611 1621
119. M. Picard, P. Giavina-Bianchi, V. Mezzano, and M. Castells Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes Clin Ther 35 2013 548 562
120. D. Gonzalez-de-Olano, I. Varez-Twose, A. Matito, L. Sanchez-Munoz, N.G. Kounis, and L. Escribano Mast cell activation disorders presenting with cerebral vasospasm-related symptoms: a "Kounis-like" syndrome? Int J Cardiol 150 2011 210 211
121. B. Ozben, and O. Erdogan The role of inflammation and allergy in acute coronary syndromes Inflamm Allergy Drug Targets 7 2008 136 144
122. M. Triggiani, V. Patella, R.I. Staiano, F. Granata, and G. Marone Allergy and the cardiovascular system Clin Exp Immunol 153 suppl 1 2008 7 11
123. C. Iribarren, I.V. Tolstykh, M.K. Miller, E. Sobel, and M.D. Eisner Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: a prospective study of 2 matched cohorts Am J Epidemiol 176 2012 1014 1024
124. B. Brunekreef, G. Hoek, P. Fischer, and F.T. Spieksma Relation between airborne pollen concentrations and daily cardiovascular and respiratory-disease mortality Lancet 355 2000 1517 1518
125. D.E. Bridgman, R. Clarke, P.H. Sadleir, J.J. Stedmon, and P. Platt Systemic mastocytosis presenting as intraoperative anaphylaxis with atypical features: a report of two cases Anaesth Intensive Care 41 2013 116 121
126. U.R. Mueller Cardiovascular disease and anaphylaxis Curr Opin Allergy Clin Immunol 7 2007 337 341
127. M. Biteker Current understanding of Kounis syndrome Expert Rev Clin Immunol 6 2010 777 788
128. N.G. Kounis, A. Mazarakis, G. Tsigkas, S. Giannopoulos, and J. Goudevenos Kounis syndrome: a new twist on an old disease Future Cardiol 7 2011 805 824
129. N.G. Kounis Coronary hypersensitivity disorder: the Kounis syndrome Clin Ther 35 2013 563 571
130. G. Shah, G. Scadding, and N. Nguyen-Lu et al. Peri-operative cardiac arrest with ST elevation secondary to gelofusine anaphylaxis - Kounis syndrome in the anaesthetic room Int J Cardiol 164 2013 e22 e26
131. V. Marcoux, S. Nosib, H. Bi, and B. Brownbridge Intraoperative myocardial infarction: Kounis syndrome provoked by latex allergy BMJ Case Rep 2013 2013
132. M. Yurtdas, and M.K. Aydin A case of coronary spasm with resultant acute myocardial infarction: likely the result of an allergic reaction Intern Med 51 2012 2161 2164
133. N.G. Kounis, A. Mazarakis, and G. Tsigkas Eosinophilic coronary periarteritis presenting with vasospastic angina and sudden death: a new cause and manifestation of Kounis syndrome? Virchows Arch 462 2013 687 688
134. T. Korn, E. Bettelli, and W. Gao et al. IL-21 initiates an alternative pathways to induce proinflammatory Th17 cells Nature 448 2007 484 488
135. I. Bohm Kounis syndrome in a patient with allergy to iodinated contrast media Int J Cardiol 151 2011 102 103
136. G. Kocabay, C.Y. Karabay, and N.G. Kounis Myocardial infarction secondary to contrast agent. Contrast effect or type II Kounis syndrome? Am J Emerg Med 30 2012 255.e1 255.e2
137. K. Miwa, and M. Fujita Cardiovascular dysfunction with low cardiac output due to a small heart in patients with chronic fatigue syndrome Intern Med 48 2009 1849 1854
138. A. Azevedo, P. Bettencourt, and J. Pimenta et al. Clinical syndrome suggestive of heart failure is frequently attributable to non-cardiac disorders - population-based study Eur J Heart Fail 9 2007 391 396
139. K.G. Hollingsworth, D.E. Jones, R. Taylor, A.M. Blamire, and J.L. Newton Impaired cardiovascular response to standing in chronic fatigue syndrome Eur J Clin Invest 40 2010 608 615
140. T.C. Theoharides Atopic conditions in search of pathogenesis and therapy Clin Ther 35 2013 544 547
141. T.C. Theoharides, and P. Conti Mast cells: the JEKYLL and HYDE of tumor growth Trends Immunol 25 2004 235 241
142. S.J. Galli, M. Grimbaldeston, and M. Tsai Immunomodulatory mast cells: negative, as well as positive, regulators of immunity Nat Rev Immunol 8 2008 478 486
143. O. Ozdemir Mast cells and the tumor-associated neoangiogenesis Med Sci Monit 12 2006 LE9 LE11
144. O. Ozdemir Immunosurveillance function of human mast cell? World J Gastroenterol 11 2005 7054 7056
145. A. Linneberg, R.K. Jacobsen, L. Jespersen, and S.Z. Abildstrom Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality J Allergy Clin Immunol 129 2012 413 419
146. D.B. Murray, J.D. Gardner, G.L. Brower, and J.S. Janicki Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats Am J Physiol Heart Circ Physiol 287 2004 H2295 H2299
147. M. Reriani, E. Raichlin, and A. Prasad et al. Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis Circulation 122 2010 958 966
148. C.G. Koch Statin therapy Curr Pharm Des 18 2012 6284 6290
149. A.S. Antonopoulos, M. Margaritis, R. Lee, K. Channon, and C. Antoniades Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials Curr Pharm Des 18 2012 1519 1530
150. F. Montecucco, A. Quercioli, F. Dallegri, G.L. Viviani, and F. Mach New evidence for nicotinic acid treatment to reduce atherosclerosis Expert Rev Cardiovasc Ther 8 2010 1457 1467
151. T.A. Jacobson A "hot" topic in dyslipidemia management - "how to beat a flush": optimizing niacin tolerability to promote long-term treatment adherence and coronary disease prevention Mayo Clin Proc 85 2010 365 379
152. T.C. Theoharides, W. Sieghart, P. Greengard, and W.W. Douglas Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein Science 207 1980 80 82
153. K.E. Barrett, and D.D. Metcalfe The histologic and functional characterization of enzymatically dispersed intestinal mast cells of nonhuman primates: effects of secretagogues and anti-allergic drugs on histamine secretion J Immunol 135 1985 2020 2026
154. F.L. Pearce, A.D. Befus, J. Gauldie, and J. Bienenstock Mucosal mast cells. II: effects of anti-allergic compounds on histamine secretion by isolated intestinal mast cells J Immunol 128 1982 2481 2486
155. R.F. Horan, A.L. Sheffer, and K.F. Austen Cromolyn sodium in the management of systemic mastocytosis J Allergy Clin Immunol 85 1990 852 855
156. C.C. Fox, E.J. Wolf, A. Kagey-Sobotka, and L.M. Lichtenstein Comparison of human lung and intestinal mast cells J Allergy Clin Immunol 81 1988 89 94
157. T. Oka, J. Kalesnikoff, P. Starkl, M. Tsai, and S.J. Galli Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice Lab Invest 92 2012 1472 1482
158. Z. Weng, B. Zhang, and S. Asadi et al. Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans PloS One 7 2012 e33805
159. S.R. Vieira Dos, M. Magerl, and P. Martus et al. Topical sodium cromoglycate relieves allergen- and histamine-induced dermal pruritus Br J Dermatol 162 2010 674 676
160. M. Merlos, M. Giral, and D. Balsa et al. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF) J Pharmacol Exp Ther 280 1997 114 121
161. M. Metz, and M. Maurer Rupatadine for the treatment of allergic rhinitis and urticaria Expert Rev Clin Immunol 7 2011 15 20
162. C. Picado Rupatadine: pharmacological profile and its use in the treatment of allergic disorders Expert Opin Pharmacother 7 2006 1989 2001
163. M. Vasiadi, K. Kalogeromitros, and D. Kempuraj et al. Rupatadine inhibits pro-inflammatory mediator secretion from human mast cells triggered by different stimuli Int Arch Allergy Immunol 151 2010 38 45
164. M. Alevizos, A. Karagkouni, and M. Vasiadi et al. Rupatadine inhibits inflammatory mediator release from human LAD2 cultured mast cells stimulated by PAF Annals Allergy Asthma Immunol 111 2013 542 547
165. S.S. Iyer, and G. Cheng Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease Crit Rev Immunol 32 2012 23 63
166. J.S. Marshall, I. Leal-Berumen, L. Nielsen, M. Glibetic, and M. Jordana Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells Clin Invest 97 1996 1122 1128
167. T.J. Lin, and A.D. Befus Differential regulation of mast cell function by IL-10 and stem cell factor J Immunol 159 1997 4015 4023
168. S.S. Palaniyandi, K. Watanabe, M. Ma, H. Tachikawa, M. Kodama, and Y. Aizawa Inhibition of mast cells by interleukin-10 gene transfer contributes to protection against acute myocarditis in rats Eur J Immunol 34 2004 3508 3515
169. S.R. Gillespie, R.R. DeMartino, and J. Zhu et al. IL-10 inhibits FcepsilonRI expression in mouse mast cells J Immunol 172 2004 3181 3188
170. P. Conti, D. Kempuraj, and K. Kandere et al. IL-10, an inflammatory/inhibitory cytokine, but not always Immunol Lett 86 2003 123 129
171. W. Guo, E. Kong, and M. Meydani Dietary polyphenols, inflammation, and cancer Nutr Cancer 61 2009 807 810
172. E.J. Middleton, C. Kandaswami, and T.C. Theoharides The effects of plant
173. Z.P. Xiao, Z.Y. Peng, M.J. Peng, W.B. Yan, Y.Z. Ouyang, and H.L. Zhu Flavonoids health benefits and their molecular mechanism Mini Rev Med Chem 11 2011 169 177
174. M. Harwood, B. Nielewska-Nikiel, J.F. Borzelleca, G.W. Flamm, G.M. Williams, and T.C. Lines A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties Food Chem Toxicol 45 2007 2179 2205
175. S. Kawanishi, S. Oikawa, and M. Murata Evaluation for safety of antioxidant chemopreventive agents Antioxid Redox Signal 7 2005 1728 1739
176. D. Kempuraj, B. Madhappan, and S. Christodoulou et al. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells Br J Pharmacol 145 2005 934 944
177. S. Yap, C. Qin, and O.L. Woodman Effects of resveratrol and flavonols on cardiovascular function: Physiological mechanisms Biofactors 36 2010 350 359
178. F. Perez-Vizcaino, and J. Duarte Flavonols and cardiovascular disease Mol Aspects Med 31 2010 478 494
179. J.J. Peterson, J.T. Dwyer, P.F. Jacques, and M.L. McCullough Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations Nutr Rev 70 2012 491 508
180. W. Mullen, J. Gonzalez, and J. Siwy et al. A pilot study on the effect of short-term consumption of a polyphenol rich drink on biomarkers of coronary artery disease defined by urinary proteomics J Agric Food Chem 59 2011 12850 12857
181. F.L. Pearce, A.D. Befus, and J. Bienenstock Effect of quercetin and other flavonoids on antigen-induced histamine secretion from rat intestinal mast cells J Allergy Clin Immunol 73 1984 819 823
182. S. Asadi, B. Zhang, and Z. Weng et al. Luteolin and thiosalicylate inhibit HgCl and thimerosal-induced VEGF release from human mast cells Int J Immunopathol Pharmacol 23 2010 1015 1020
183. Z. Deqiu, L. Kang, Y. Jiali, L. Baolin, and L. Gaolin Luteolin inhibits inflammatory response and improves insulin sensitivity in the endothelium Biochimie 93 2011 506 512
184. C. Ando, N. Takahashi, and S. Hirai et al. Luteolin, a food-derived flavonoid, suppresses adipocyte-dependent activation of macrophages by inhibiting JNK activation FEBS Lett 583 2009 3649 3654
185. D. Papaliodis, W. Boucher, D. Kempuraj, and T.C. Theroharides The flavonoid luteolin inhibits niacin-induced flush Br J Pharmacol 153 2008 1382 1387
186. D. Kalogeromitros, M. Makris, C. Chliva, X. Aggelides, D. Kempuraj, and T.C. Theoharides A quercetin containing supplement reduces niacin-induced flush in humans Int J Immunopathol Pharmacol 21 2008 509 514
187. R.H. Schneider, C.E. Grim, and M.V. Rainforth et al. Stress reduction in the secondary prevention of cardiovascular disease: randomized, controlled trial of transcendental meditation and health education in Blacks Circ Cardiovasc Qual Outcomes 5 2012 750 758
188. W. Jiang, E.J. Velazquez, and M. Kuchibhatla et al. Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial JAMA 309 2013 2139 2149